SATB1 Expression Is Associated with Biologic Behavior in Colorectal Carcinoma In Vitro and In Vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SATB1 Expression Is Associated with Biologic Behavior in Colorectal Carcinoma In Vitro and In Vivo
Authors
Keywords
Colorectal cancer, Differentiated tumors, Transcription factors, Antigen-presenting cells, Apoptosis, Carcinomas, Cytoplasmic staining, Cyclins
Journal
PLoS One
Volume 8, Issue 1, Pages e47902
Publisher
Public Library of Science (PLoS)
Online
2013-01-12
DOI
10.1371/journal.pone.0047902
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CLCA2 as a p53-Inducible Senescence Mediator
- (2015) Chizu Tanikawa et al. NEOPLASIA
- Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- (2012) Michael T Parsons et al. JOURNAL OF MEDICAL GENETICS
- In vitro stability of APC gene sequences and the influence of DNA repair status
- (2012) C. L. Turnbull et al. MUTAGENESIS
- The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members
- (2012) Corentin Laulier et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- BRCAness: Finding the Achilles Heel in Ovarian Cancer
- (2012) G. Rigakos et al. ONCOLOGIST
- ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics
- (2012) Georgia Levidou et al. World Journal of Surgical Oncology
- The American College of Gastroenterology Emily Couric Lecture—The Adenoma–Carcinoma Sequence Revisited: Has the Era of Genetic Tailoring Finally Arrived?
- (2011) Dennis J Ahnen AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma
- (2011) Hongxiang Chen et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features
- (2010) CHAO CHENG et al. APMIS
- Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye
- (2010) Na Niu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression and distribution of immunoglobulin G and its receptors in the human nervous system
- (2010) Na Niu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Overexpression of SATB1 in Laryngeal Squamous Cell Carcinoma
- (2010) Xu-Dong Zhao et al. ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery
- Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia
- (2009) Na Niu et al. LABORATORY INVESTIGATION
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
- (2008) Sérgia Velho et al. BMC CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features
- (2008) E. Ioachim INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- SATB1 is required for CD8 coreceptor reversal
- (2008) Hui Nie et al. MOLECULAR IMMUNOLOGY
- SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis
- (2008) Hye-Jung Han et al. NATURE
- Prognostic and predictive factors in colorectal cancer
- (2008) I Zlobec et al. POSTGRADUATE MEDICAL JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now